Drugs / CD34+ selected cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02258490 | — | acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome | Emory University | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ selected cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02258490 ↗ |
| Modality | Cell therapy | “hematopoietic progenitor cell (HPC) transplants” NCT02258490 ↗ |